UNC Researchers Demonstrate Drug’s Effectiveness in Drawing Out Dormant HIV from Immune Cells
The study shows that drug citarinostat can awaken hidden HIV, advancing efforts towards a potential cure for the complex virus.
The study shows that drug citarinostat can awaken hidden HIV, advancing efforts towards a potential cure for the complex virus.
Biochemistry, HIV/AIDS, News, Research, Virology, Vital Signs
The prestigious honor recognizes biochemist Jean Cook, PhD, and her work on cancer development and the human cell cycle, a biological process crucial for development, healing, and continued maintenance of…
Groundbreaking CAR-T cell clinical trial led by Saira Sheikh, MD, showcased on national television.
In a new paper, researchers propose treating health data as essential national infrastructure, balancing patient empowerment, privacy, innovation, and public good.
Bioinformatics, General Medicine, Genetics And Aging, News, Pediatrics And Children's Health, Research, Vital Signs
A geneticist at the UNC School of Medicine has coordinated the development of Mondo, the world’s first standardized rare disease coding tool. Mondo is designed to streamline the diagnosis and…
Many of the basic science departments rank in the top 10 in National Institutes of Health funding for federal fiscal year 2025 and 10 clinical departments rank in the top…
New UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy.
Cancer, Immunology And Microbiology, MICROIMM Featured, News, Research
Jonathan Oberlander, Professor of Social Medicine, is co-editor of a new special issue on Public Health Under Siege.
Faculty, Global Health, News, Research, School of Medicine, Social Medicine, Vital Signs
The tool is a one-stop resource for downloadable, shareable, and aggregated health data, which will help researchers, policymakers and healthcare providers better respond to concerning cancer trends and health needs…
Cancer, News, North Carolina, Oncology, Research, Vital Signs
UNC researchers have received ~$7.3M from NHLBI to lead the Rare Bronchiectatic Diseases Consortium, advancing research on four rare lung diseases that cause progressive bronchiectasis. The effort builds on UNC’s…